China National Building Material Company Limited
China National Building Material Company Limited (CBUMY) Financial Performance & Income Statement Overview
Analyze China National Building Material Company Limited (CBUMY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
China National Building Material Company Limited (CBUMY) Income Statement & Financial Overview
Review China National Building Material Company Limited CBUMY income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $46.45B | $37.02B | $50.64B | $57.21B |
| Cost of Revenue | $39.22B | $31.001B | $43.50B | $44.50B |
| Gross Profit | $7.23B | $6.02B | $7.14B | $12.70B |
| Gross Profit Ratio | $0.16 | $0.16 | $0.14 | $0.22 |
| R&D Expenses | $1.07B | $1.07B | $4.58B | $4.58B |
| SG&A Expenses | $7.90B | $4.10B | $11.93B | $1.34B |
| Operating Expenses | $6.49B | $5.39B | $113.60M | $10.27B |
| Total Costs & Expenses | $45.71B | $36.39B | $43.61B | $54.77B |
| Interest Income | $0.00 | $0.00 | $51.79M | $221.98M |
| Interest Expense | $0.00 | $0.00 | $425.67M | $0.00 |
| Depreciation & Amortization | $3.30B | $3.48B | $3.48B | $3.27B |
| EBITDA | $3.89B | $4.14B | $4.93B | $8.39B |
| EBITDA Ratio | $0.08 | $0.11 | $0.10 | $0.15 |
| Operating Income | $740.05M | $666.17M | $1.45B | $5.12B |
| Operating Income Ratio | $0.02 | $0.02 | $0.03 | $0.09 |
| Other Income/Expenses (Net) | $347.40M | -$2.83B | $12.27B | -$5.30B |
| Income Before Tax | $1.09B | -$760.26M | $4.76B | $2.21B |
| Income Before Tax Ratio | $0.02 | -$0.02 | $0.09 | $0.04 |
| Income Tax Expense | $457.54M | $162.008M | $778.38M | $210.11M |
| Net Income | -$397.95M | -$1.35B | $1.51B | $949.14M |
| Net Income Ratio | -$0.009 | -$0.04 | $0.03 | $0.02 |
| EPS | -$0.08 | -$0.16 | $8.55 | $5.63 |
| Diluted EPS | -$0.08 | -$0.16 | $8.95 | $5.63 |
| Weighted Avg Shares Outstanding | $8.43B | $8.43B | $176.57M | $168.70M |
| Weighted Avg Shares Outstanding (Diluted) | $8.43B | $8.43B | $168.70M | $168.70M |
The company's financials show resilient growth, with revenue advancing from $57.21B in Q3 2023 to $46.45B in Q2 2024. Gross profit remained healthy with margins at 16% in Q2 2024 compared to 22% in Q3 2023. Operating income hit $740.05M last quarter, sustaining a consistent 2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.89B. Net income rose to -$397.95M, while earnings per share reached -$0.08. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan